Avandia Settlements and Verdicts

Avandia, GlaxoSmithKline's widely prescribed oral diabetes drug, currently faces lawsuits from hundreds of users across the country claiming to have suffered heart attacks, strokes, congestive heart failure, bone fractures, vision loss, and other injuries as a result of Avandia use.

Multi-District Litigation (MDL)

Federal lawsuits have been consolidated in a Multi-District Litigation (MDL) in the Eastern Districts of Pennsylvania. Cases are also pending in state courts while lawyers continue to review new Avandia lawsuits. Assigned to oversee all of the MDL Avandia lawsuits in the Eastern District of Pennsylvania is U.S. District Judge Cynthia Rufe. Judge Rufe issued a pretrial order that calls for the first Avandia trial date to be scheduled between June 1, 2010 and September 30, 2010. All of the federal Avandia cases are centralized before Judge Rufe to avoid duplication discovery, inconsistent rulings, and to conserve the resources of the parties and court.

Discovery Plan

The court approved an initial scheduling proposal and discovery plan on September 26, 2008. The discovery plan requires the first Avandia cases to be prepared for trial over the next two years. "Discovery Group 1" will consist of 100 cases filed directly in the Eastern District of Pennsylvania. A subset of these cases will later be selected for the "Initial Trial Pool" of cases, which will be the first to go to trial.

Timeline

The scheduling order requires all case-specific discoveries to be completed by November 24, 2009. Defendant's expert reports are due by February 15, 2010, and the deadline for completion of Daubert motions and expert depositions is set for April 15, 2010.

Consult a Lawyer

If you or a loved one has been harmed by Avandia, you should contact an Avandia attorney to find out whether you are eligible for compensation for your injuries.

Share |

Keyword Tags: defective drugs, pharmaceutical litigation

Still Have a Question? Ask a Lawyer in Your Area